Unveiling the antibody–drug conjugates portfolio in battling Triple-negative breast cancer: Therapeutic trends and Future horizon
Avinash Khadela, Shruti Soni, Aayushi C. Shah, Aanshi J. Pandya, Kaivalya Megha, Nirjari Kothari, Avinash CB
Topics & Concepts
Triple-negative breast cancerCancer researchAntibody-drug conjugateBreast cancerTrastuzumabMedicineEstrogen receptorTumor microenvironmentCancerBystander effectAntibodyOncologyInternal medicineMonoclonal antibodyImmunologyHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchCancer Treatment and Pharmacology